Application 091053
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACARBOSE | ACARBOSE | TABLET;ORAL | 25MG | No | No |
| 002 | ACARBOSE | ACARBOSE | TABLET;ORAL | 50MG | No | No |
| 003 | ACARBOSE | ACARBOSE | TABLET;ORAL | 100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091053-001 | ACARBOSE | ACARBOSE | 25MG | TABLET / ORAL | 2011-01-06 | ||
| A091053-002 | ACARBOSE | ACARBOSE | 50MG | TABLET / ORAL | 2011-01-06 | ||
| A091053-003 | ACARBOSE | ACARBOSE | 100MG | TABLET / ORAL | 2011-01-06 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A091053-001 | ACARBOSE | 25MG | TABLET / ORAL | 2011-01-06 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A091053-002 | ACARBOSE | 50MG | TABLET / ORAL | 2011-01-06 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A091053-003 | ACARBOSE | 100MG | TABLET / ORAL | 2011-01-06 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A091053-001 | ACARBOSE | 25MG | TABLET / ORAL | 2011-01-06 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A091053-002 | ACARBOSE | 50MG | TABLET / ORAL | 2011-01-06 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A091053-003 | ACARBOSE | 100MG | TABLET / ORAL | 2011-01-06 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A091053-001 | ACARBOSE | 25MG | TABLET / ORAL | 2011-01-06 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A091053-002 | ACARBOSE | 50MG | TABLET / ORAL | 2011-01-06 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A091053-003 | ACARBOSE | 100MG | TABLET / ORAL | 2011-01-06 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A091053-001 | ACARBOSE | 25MG | TABLET / ORAL | 2011-01-06 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A091053-002 | ACARBOSE | 50MG | TABLET / ORAL | 2011-01-06 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A091053-003 | ACARBOSE | 100MG | TABLET / ORAL | 2011-01-06 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acarbose | ACARBOSE | Bryant Ranch Prepack | 1ba7a072-03b0-41f2-be7a-101145bdef3a | 2026-08-11 | Adverse reactions | Acarbose ACARBOSE |
| Acarbose | ACARBOSE | Bryant Ranch Prepack | 067c0adc-7322-489d-9baa-1d061b37be36 | 2026-07-16 | Adverse reactions | Acarbose ACARBOSE |
| Acarbose | ACARBOSE | Strides Pharma Science Limited | 656769ee-e292-4950-83df-a38e6b1a9d6e | 2026-07-15 | Adverse reactions | Acarbose ACARBOSE |
| Acarbose | ACARBOSE | PD-Rx Pharmaceuticals, Inc. | 722ce9eb-8f7b-4651-a287-d53dd7ab3707 | 2026-06-24 | Adverse reactions | Acarbose ACARBOSE |
| Acarbose | ACARBOSE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 29939129-7d09-4c22-bf3e-491a8a97f4c4 | 2026-06-18 | Adverse reactions | Acarbose ACARBOSE |
| Acarbose | ACARBOSE | Chartwell RX, LLC | d1b627e1-d78d-47dd-93f5-2bf4998466ba | 2025-12-09 | Adverse reactions | Acarbose ACARBOSE |
| Acarbose | ACARBOSE | Hikma Pharmaceuticals USA Inc. | 352dd336-d3f9-4ac5-a000-91d3aef7aca3 | 2024-07-19 | Adverse reactions | Acarbose ACARBOSE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.